Both expression and secretion of S100A12 are increased in the serum and colon tissues from patients with IBD, and S100A12 levels in feces can be used as an indicator of mucosal healing and disease severity (15, 46). The gene discussed is S100A12; the disease is irritable bowel syndrome.